Yambe Minoru, Kurose Yuki, Hasegawa Kaoru, Kikuta Hisashi, Sumiyoshi Takenori, Sekiguchi Yuko, Kameyama Takeyoshi, Komaru Tatsuya, Kumagai Koji
Tohoku Medical and Pharmaceutical University Sendai Japan.
J Arrhythm. 2024 Jun 23;40(4):858-866. doi: 10.1002/joa3.13094. eCollection 2024 Aug.
Blood pressure variability has been found to be a predictor of a stroke, heart failure, and ischemic heart disease that is independent of blood pressure control. This study used the variability independent of the mean (VIM) to evaluate the visit-to-visit blood pressure variability in patients previously undergoing catheter ablation (CA) of paroxysmal atrial fibrillation (PAF), and its relationship with AF recurrence was examined.
The subjects were 274 consecutive PAF patients who underwent CA at our hospital. Finally, 237 subjects were included in the analysis. The mean follow-up period was 29.6 months, during which 37 subjects had recurrences, and 200 did not. During the outpatient blood pressure examinations, the VIM of the systolic blood pressure (VIM SBP) was significantly higher in the recurrence group, suggesting that blood pressure variability is associated with recurrence. The Cox proportional hazards ratio of the VIM SBP was significantly higher in the recurrence (4.839) than no-recurrence group, even after an adjustment, suggesting that the extent of the variability was a risk factor of recurrence post-CA. In addition, the Cox proportional hazard ratio for recurrence was significantly lower in the patients taking dihydropyridine calcium channel blockers, suggesting that the risk of recurrence may differ depending on the type of antihypertensive drug.
Blood pressure variability may be a risk for AF recurrence after CA.
血压变异性已被发现是中风、心力衰竭和缺血性心脏病的一个预测指标,且独立于血压控制情况。本研究采用独立于均值的变异性(VIM)来评估既往接受阵发性心房颤动(PAF)导管消融(CA)患者的就诊间血压变异性,并研究其与房颤复发的关系。
研究对象为我院连续274例接受CA的PAF患者。最终,237例受试者纳入分析。平均随访期为29.6个月,在此期间37例受试者复发,200例未复发。在门诊血压检查中,复发组的收缩压VIM(VIM SBP)显著更高,提示血压变异性与复发有关。即使经过调整,复发组的VIM SBP的Cox比例风险比(4.839)仍显著高于未复发组,提示变异性程度是CA术后复发的一个危险因素。此外,服用二氢吡啶类钙通道阻滞剂的患者复发的Cox比例风险比显著更低,提示复发风险可能因降压药物类型而异。
血压变异性可能是CA术后房颤复发的一个风险因素。